Imagion Biosystems is pleased to announce it is a proud recipient of an Innovations Connections grant from the Australian Government’s Department of Industry, Science, Energy and Resources.
Awarded as part of the funding program delivered by the CSIRO, the $50,000 grant will be used to support preclinical research between Imagion and Monash University’s Biomedicine Discovery Institute – to develop an early proof of concept use for MagSenseTM as a prostate cancer imaging agent.
Imagion will look to use this data in further R&D, as the Company seeks to potentially address a clearly unmet medical need for a non-invasive bio-safe diagnostic technology in the $6.2 Billion (2019) prostate cancer market. For more on this grant, see the announcement below or click the following link: https://bit.ly/3qNxQbT
IBX Price at posting:
17.5¢ Sentiment: None Disclosure: Not Held
